GlaxoSmithKline has opened an ultra-high-throughput screening
facility at its site in Tres Cantos, Spain, marking a significant
milestone in the company's bid to develop a more industrialised
approach to the process of drug discovery.
Researchers in Germany, Switzerland and the USA have completed a
genome map of the bacteria Helicobacter hepaticus in the
hope of providing new drug targets to treat a related organism that
causes gastrointestinal disease in humans.
UK informatics company Inpharmatica has added a whole new suite of
ADME (absorption, distribution, metabolism and excretion)
capabilities to its drug lead optimisation services with the
purchase of a lab and intellectual property...
Just over a year after acquiring the FSG business from Vivendi for
$360 million (€307m), Pall Corp has reported a healthy hike in
fiscal third-quarter sales and profits and once again raised its
earnings forecast for 2003.